NATURE’S SUNSHINE PRODUCTS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $169.32 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $169.32M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $166.92M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $161.55M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $166.70M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $169.32M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $166.92M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $161.55M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $166.70M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $163.68M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $167.10M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $160.99M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $162.62M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $156.40M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $159.71M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $159.54M 10-K · filed 2026-03-10 |
| 2023-09-30 | $152.01M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $149.40M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $146.72M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $147.05M 10-K · filed 2025-03-11 |
| 2022-09-30 | $141.75M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $144.48M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $149.78M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $161.40M 10-K · filed 2024-03-12 |
| 2021-09-30 | $147.63M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $147.15M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $141.50M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $157.23M 10-K · filed 2023-03-16 |
| 2020-09-30 | $148.24M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $139.24M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $132.57M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $129.44M 10-K · filed 2022-03-08 |
| 2019-09-30 | $126.77M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $124.74M 10-Q · filed 2020-11-09 |
| 2019-03-31 | $122.02M 10-Q · filed 2020-11-09 |
| 2018-12-31 | $120.57M 10-K · filed 2021-03-10 |
| 2018-09-30 | $123.49M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $121.66M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $121.01M 10-Q · filed 2018-05-10 |
| 2018-01-01 | $119.73M 10-K · filed 2019-03-08 |
| 2017-12-31 | $119.73M 10-K · filed 2020-03-11 |
| 2017-09-30 | $136.32M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $133.68M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $133.55M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $132.40M 10-K · filed 2019-03-08 |
| 2016-09-30 | $142.41M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $138.62M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $136.89M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $136.26M 10-K · filed 2019-03-08 |
| 2015-09-30 | $134.55M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $134.21M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $132.78M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $128.96M 10-K · filed 2018-03-16 |
| 2013-12-31 | $105.26M 10-K · filed 2017-03-14 |
| 2012-12-31 | $115.64M 10-K · filed 2016-03-14 |
| 2011-12-31 | $87.44M 10-K · filed 2015-03-13 |
| 2011-06-30 | $83.56M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $68.38M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |